Join Zealand Pharma for an Exciting Capital Markets Day
Get ready for an engaging experience as Zealand Pharma A/S (NASDAQ: ZEAL), a prominent biotechnology company renowned for its development of peptide-based medicines, gears up to host its Capital Markets Day. This special event will take place in a vibrant venue in London, where attendees will witness insightful presentations from esteemed management and leading external experts in the realms of obesity and metabolism.
Event Details: What to Expect
On the day of the event, join us for a series of informative sessions designed to highlight the innovative strides Zealand Pharma is making in the biotechnology sector. It’s an opportunity to delve deeper into the company’s vision, explore the future of peptide-based treatments, and engage in discussions with seasoned experts.
Key Event Logistics
The Capital Markets Day is scheduled to run from 1:00 PM to 5:30 PM GMT, with the venue at Goldman Sachs International, located at Plumtree Court, 2 Stonecutter Street, London. Whether you choose to attend in person or participate virtually, registration is essential.
Notable Speakers and Their Contributions
Zealand Pharma has organized a robust agenda featuring presentations from influential leaders within the company.
Meet the Zealand Pharma Team
- Adam Steensberg, Chief Executive Officer
- Henriette Wennicke, Chief Financial Officer
- David Kendall, Chief Medical Officer
- Eric Cox, Chief Commercial Officer
- Utpal Singh, Chief Scientific Officer
Alongside these internal experts, several renowned external specialists will also share their knowledge. Each speaker brings unique insights to the table, turning the event into a treasure trove of information for attendees.
External Expertise
- Dr. Carel Le Roux, a prominent figure in obesity research from University College Dublin.
- Jonathan Roth, an esteemed metabolic researcher recognized for his groundbreaking work in amylin-leptin biology.
- Louis J. Aronne, a leader in metabolic research at Weill Cornell Medical College.
About Zealand Pharma: An Overview
Founded in 1998 and headquartered in Copenhagen, Zealand Pharma is at the forefront of biotechnology innovation. The company focuses on discovering and cultivating peptide-based therapies that address significant medical needs. With over 10 drug candidates advancing into clinical development, Zealand Pharma stands out as a leader in the industry, already bringing two products to the market and three more in late-stage development.
The company collaborates with numerous pharmaceutical partners and holds several commercial agreements for its marketed products, reinforcing its commitment to improving patient care through advanced therapeutic options.
Connect with Zealand Pharma
As part of its commitment to transparency and engagement with stakeholders, Zealand Pharma ensures that a replay of the event will be available on its official website shortly after the presentations conclude. For further insights and updates, interested parties are invited to visit Zealand Pharma's official website.
Frequently Asked Questions
What is Zealand Pharma's Capital Markets Day?
The Capital Markets Day is an event organized by Zealand Pharma to present its innovative research and development efforts, focusing on peptide-based medicines.
When is the Capital Markets Day scheduled to take place?
The event will be held from 1:00 PM to 5:30 PM GMT in London.
Who are the key speakers at the event?
Key speakers include Zealand Pharma executives like Adam Steensberg and external experts such as Dr. Carel Le Roux and Jonathan Roth.
How can one attend the event?
F attendees can register for the event to attend in person or join virtually.
What does Zealand Pharma specialize in?
Zealand Pharma specializes in discovering and developing peptide-based medicines aimed at treating serious health conditions, particularly in metabolism and obesity.
